211 related articles for article (PubMed ID: 7862845)
1. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM).
Kirby LG; Rowan GA; Smith RL; Lucki I
Psychopharmacology (Berl); 1994 Jan; 113(3-4):351-60. PubMed ID: 7862845
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil.
Rowan GA; Lucki I
Psychopharmacology (Berl); 1992; 107(1):103-12. PubMed ID: 1317039
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus properties of methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors.
Nielsen EB; Jepsen SA; Nielsen M; Braestrup C
Life Sci; 1985 Jan; 36(1):15-23. PubMed ID: 2981379
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of ethyl-beta-carboline-3-carboxylate at two training doses in rats.
Rowlett JK; Wilcox KM; Woolverton WL
Psychopharmacology (Berl); 1999 Aug; 145(3):324-32. PubMed ID: 10494582
[TBL] [Abstract][Full Text] [Related]
5. Inverse agonist properties of the FG 7142 discriminative stimulus.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1991 Jan; 38(1):99-104. PubMed ID: 1850137
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors.
Stephens DN; Shearman GT; Kehr W
Psychopharmacology (Berl); 1984; 83(3):233-9. PubMed ID: 6089245
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and the discriminative stimulus effects of negative GABAA modulators, or inverse agonists, in diazepam-treated rhesus monkeys.
McMahon LR; Gerak LR; France CP
J Pharmacol Exp Ther; 2006 Aug; 318(2):907-13. PubMed ID: 16705082
[TBL] [Abstract][Full Text] [Related]
9. Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate.
Yang XM; Luo ZP; Zhou JH
J Pharmacol Exp Ther; 1989 Jul; 250(1):358-63. PubMed ID: 2545863
[TBL] [Abstract][Full Text] [Related]
10. Interaction of beta-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors.
Im HK; Im WB; Carter DB; McKinley DD
Br J Pharmacol; 1995 Mar; 114(5):1040-4. PubMed ID: 7780638
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine receptor mediated discriminative cues: effects of GABA-ergic drugs and inverse agonists.
Nielsen EB; Valentine JD; Holohean AM; Appel JB
Life Sci; 1983 Nov; 33(22):2213-20. PubMed ID: 6316057
[TBL] [Abstract][Full Text] [Related]
12. DMCM: a potent convulsive benzodiazepine receptor ligand.
Petersen EN
Eur J Pharmacol; 1983 Oct; 94(1-2):117-24. PubMed ID: 6317396
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of alprazolam.
Gommans J; Hijzen TH; Maes RA; Olivier B
Psychopharmacology (Berl); 2000 Feb; 148(2):146-52. PubMed ID: 10663429
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine and beta-carboline interactions with GABAA receptor-gated chloride channels in mammalian cultured spinal cord neurons.
Mehta AK; Ticku MK
J Pharmacol Exp Ther; 1989 May; 249(2):418-23. PubMed ID: 2542529
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. I. Acute effects of ethanol.
Buck KJ; Harris RA
J Pharmacol Exp Ther; 1990 May; 253(2):706-12. PubMed ID: 2160007
[TBL] [Abstract][Full Text] [Related]
16. Discriminative stimulus properties of CGS 9896: interactions within the GABA/benzodiazepine receptor complex.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1988 Oct; 31(2):249-54. PubMed ID: 2854261
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonist properties of the THBC discriminative stimulus: asymmetrical generalization with FG 7142.
Leidenheimer NJ; Schechter MD
Pharmacol Biochem Behav; 1991 Mar; 38(3):519-25. PubMed ID: 1648746
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys.
McMahon LR; Gerak LR; Carter L; Ma C; Cook JM; France CP
J Pharmacol Exp Ther; 2002 Feb; 300(2):505-12. PubMed ID: 11805210
[TBL] [Abstract][Full Text] [Related]
19. Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
De Boer SF; Katz JL; Valentino RJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):335-42. PubMed ID: 1625207
[TBL] [Abstract][Full Text] [Related]
20. Negative GABA(A) modulators attenuate the discriminative stimulus effects of benzodiazepines and the neuroactive steroid pregnanolone in rhesus monkeys.
McMahon LR; France CP
Psychopharmacology (Berl); 2005 Oct; 181(4):697-705. PubMed ID: 15983789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
